Ruppert-Junck, Marina C. http://orcid.org/0000-0002-9025-7058
Heinecke, Vanessa
Librizzi, Damiano
Steidel, Kenan
Beckersjürgen, Maya
Verburg, Frederik A.
Schurrat, Tino
Luster, Markus
Müller, Hans-Helge
Timmermann, Lars
Eggers, Carsten
Pedrosa, David
Funding for this research was provided by:
Philipps-Universität Marburg
Article History
Received: 8 February 2024
Accepted: 7 June 2024
First Online: 17 June 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical Faculty of the Philipps-University of Marburg.
: Informed consent was obtained from all individual participants included in the study.
: D.P. has received honoraria as a speaker at symposia sponsored by Boston Scientific Corp, Medtronic, AbbVie Inc, Stadapharm, Zambon and Esteve Pharmaceuticals GmbH. He received payments as a consultant for AbbVie, Boston Scientific Corp, Bayer, BIAL and Desitin, and he received a scientific grant from Boston Scientific Corp for a project entitled: “Sensor-based optimisation of Deep Brain Stimulation settings in Parkinson’s disease” (COMPARE-DBS). Finally, D.P. was reimbursed by Esteve Pharmaceuticals GmbH, Desitin and Boston Scientific Corp for travel expenses to attend congresses. Between September 2021 and September 2023 L.T. received occasional payments as a consultant for Boston Scientific, L.T. received honoraria as a speaker on symposia sponsored by Boston Scientific, AbbVIE, Novartis, Neuraxpharm, Teva, the Movement Disorders Society und DIAPLAN. The institution of L.T., not L.T. personally received funding by Boston Scientific, the German Research Foundation, the German Ministry of Education and Research, the Otto-Loewi-Foundation and the Deutsche Parkinson Vereinigung. Neither L.T. nor any member of his family holds stocks, stock options, patents or financial interests in any of the above mentioned companies or their competitors. L.T. serves as the president of the German Neurological Society without any payment or any income. C.E. has received honoraria as speaker or consultant from AbbVie Inc., Stada Pharma Inc., Everpharma Inc. and Philyra. All remaining authors have no relevant financial or non-financial interests to disclose.